Supply India Gleevec anti-cancer effect network 13621079267 Gleevec is fake in China

'r', Gleevec (including Indian Gleevec) is known as the "miracle anti-cancer drug". It is an internationally recognized first-line treatment drug for chronic myeloid leukemia and can effectively prolong patients' lives. However, patients need to take it for a long time, one box per month, and it is expensive. Many people cannot afford such an expensive price. So what is the reason why Gleevec is so high? What's the solution? This article will reveal the answer for you.
'r ', Novartis' Gleevec drug patent is the main reason for the high price of Gleevec
'r ', Gleevec is a patented product of Novartis of Switzerland, and Novartis of Switzerland invested in the research and development of Gleevec It is huge, and it is also the global patent owner of Gleevec. In countries in the world that recognize drug patents, the price is very expensive.
'r ', There is no doubt that before the patent expires, Novartis Gleevec has a monopoly on its price. In fact, over the years since Gleevec came out, its research and development costs have been recovered dozens of times, and Novartis has made a lot of money.
'r ', One thing that is very strange is that the price of Gleevec in different countries varies greatly. This shows that its profit potential and flexibility are very large. Novartis has its sights on China's huge market. It has rare products to buy, monopolizes prices and keeps them high, and makes a lot of life-saving money from Chinese cancer patients.
'r ', Other reasons besides patents
'r ', Are there other reasons besides high price? The answer is yes. In addition to the above-mentioned patent factors, the selling prices vary from country to country, indicating that there are also non-patent factors involved.
'r ', In fact, the prices of all anti-cancer drugs imported into China are inflated. For example, the tariff on imported medicines from China is generally 0.0%, and if the medicine is sold into hospitals, an additional 10% will be added. Together, they account for more than a quarter of the pricing. Repeated charges made the cancer patient and Jiang Ting in pain even worse and overwhelmed.
'r ', What is worth pondering is: before the international monopoly price of drugs is broken, can we think of some ways and introduce relevant policies, such as significantly reducing tariffs and significantly reducing the profits of dealers and hospitals? Or allow part of the cost of these drugs to be included in medical insurance, so that more cancer patients can afford these drugs, prolonging and saving their lives.
'r ', The most fundamental way to solve the high price of Gleevec is independent research and development
'r ', If China wants to solve the problem of high-priced anti-cancer drugs, it should inspire the determination and courage of Chinese scientific researchers, Put these cancer-treating drugs into production as soon as possible to meet the urgent needs of patients.
'r ', Imagine if the self-developed domestically produced Gleevec was released and Chinese cancer patients were allowed to take domestically produced drugs, the prices of expensive imported drugs would naturally come down.
'r ', It can be seen that the best way at present is to break the international monopoly and develop domestically produced drugs with reliable efficacy and affordable prices. For example, China's Betta Pharmaceuticals' Kemena has been put into clinical practice. China has become the third country after the United States and the United Kingdom to have fully independent intellectual property rights for targeted anti-cancer drugs. Experts in the pharmaceutical and medical circles rate Kemena very highly. , was praised by Chen Zhu, the then Minister of Health, as "two bombs and one satellite" in the field of people's livelihood. However, it is regrettable that the selling price of Kemena in China is still higher than that of Gleevec in India. This issue is worth thinking about.